<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://jam.alphagenics.co/blog/jam-clinical-trials-law-ethics-glp1-black-patients/</loc><news:news><news:publication><news:name>Alphagenics Jamaica</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-07</news:publication_date><news:title>Clinical trials in Jamaica: no law, and few Black patients in GLP-1 data</news:title></news:news></url><url><loc>https://jam.alphagenics.co/blog/jam-drug-registration-backlog-400-medicines-tufton/</loc><news:news><news:publication><news:name>Alphagenics Jamaica</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-07</news:publication_date><news:title>Jamaica&#x27;s drug registration backlog: 400 medicines waiting</news:title></news:news></url><url><loc>https://jam.alphagenics.co/blog/jam-glp1-obesity-tufton-who-guideline-nhf-access/</loc><news:news><news:publication><news:name>Alphagenics Jamaica</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-07</news:publication_date><news:title>GLP-1 drugs in Jamaica: obesity, cost and who gets access</news:title></news:news></url><url><loc>https://jam.alphagenics.co/blog/jam-glutathione-type-2-diabetes-uwi-mona-study/</loc><news:news><news:publication><news:name>Alphagenics Jamaica</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-07</news:publication_date><news:title>Glutathione and type 2 diabetes: a UWI Mona study and the human data</news:title></news:news></url><url><loc>https://jam.alphagenics.co/blog/jam-import-permit-medicines-glp1-pens-customs/</loc><news:news><news:publication><news:name>Alphagenics Jamaica</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-07</news:publication_date><news:title>Importing medicines into Jamaica: permits, couriers and GLP-1 pens</news:title></news:news></url><url><loc>https://jam.alphagenics.co/blog/jam-insulin-monopoly-fair-trading-commission-acado-massy/</loc><news:news><news:publication><news:name>Alphagenics Jamaica</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-07</news:publication_date><news:title>Insulin in Jamaica: the Fair Trading Commission&#x27;s monopoly ruling</news:title></news:news></url><url><loc>https://jam.alphagenics.co/blog/jam-ozempic-instagram-unregistered-glp1-pharmacy-council/</loc><news:news><news:publication><news:name>Alphagenics Jamaica</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-07</news:publication_date><news:title>Ozempic on Instagram: Jamaica&#x27;s unregistered GLP-1 problem</news:title></news:news></url><url><loc>https://jam.alphagenics.co/blog/jam-peptide-guide-jamaican-physicians/</loc><news:news><news:publication><news:name>Alphagenics Jamaica</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-07</news:publication_date><news:title>The world of peptides: a guide for Jamaican physicians</news:title></news:news></url><url><loc>https://jam.alphagenics.co/blog/jam-pharmacy-act-1975-doctors-dispensing-nurse-prescribing/</loc><news:news><news:publication><news:name>Alphagenics Jamaica</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-07</news:publication_date><news:title>Jamaica&#x27;s Pharmacy Act: doctor dispensing, nurse prescribing, e-scripts</news:title></news:news></url><url><loc>https://jam.alphagenics.co/blog/jam-pharmwatch-glp1-adverse-reaction-reporting/</loc><news:news><news:publication><news:name>Alphagenics Jamaica</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-07</news:publication_date><news:title>PharmWatch Jamaica: reporting GLP-1 side effects and fake pens</news:title></news:news></url><url><loc>https://jam.alphagenics.co/blog/jam-retatrutide-unapproved-triple-agonist-jamaica-law/</loc><news:news><news:publication><news:name>Alphagenics Jamaica</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-07</news:publication_date><news:title>Retatrutide in Jamaica: an unapproved triple agonist and the law</news:title></news:news></url><url><loc>https://jam.alphagenics.co/blog/jam-telemedicine-e-prescriptions-glp1-js-359/</loc><news:news><news:publication><news:name>Alphagenics Jamaica</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-07</news:publication_date><news:title>Telemedicine in Jamaica: GLP-1 prescriptions, e-scripts and JS 359</news:title></news:news></url></urlset>
